Cargando…

Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?

BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among a...

Descripción completa

Detalles Bibliográficos
Autores principales: Strunz, Patrick-Pascal, Maire, Maxime Le, Heusinger, Tobias, Hammel, Ludwig, Gernert, Michael, Schwaneck, Eva C., Callhoff, Johanna, Portegys, Jan, Schmalzing, Marc, Tony, Hans-Peter, Froehlich, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076400/
https://www.ncbi.nlm.nih.gov/pubmed/34618212
http://dx.doi.org/10.1007/s00393-021-01104-1
_version_ 1785020123104411648
author Strunz, Patrick-Pascal
Maire, Maxime Le
Heusinger, Tobias
Hammel, Ludwig
Gernert, Michael
Schwaneck, Eva C.
Callhoff, Johanna
Portegys, Jan
Schmalzing, Marc
Tony, Hans-Peter
Froehlich, Matthias
author_facet Strunz, Patrick-Pascal
Maire, Maxime Le
Heusinger, Tobias
Hammel, Ludwig
Gernert, Michael
Schwaneck, Eva C.
Callhoff, Johanna
Portegys, Jan
Schmalzing, Marc
Tony, Hans-Peter
Froehlich, Matthias
author_sort Strunz, Patrick-Pascal
collection PubMed
description BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among axSpA patients was conducted to determine the need for an axSpA exercise app. MATERIALS AND METHODS: An anonymous online survey among axSpA patients of the German Bechterew’s Disease Association was conducted using a questionnaire; data were analysed using Excel, and GraphPad Prism. RESULTS: Four hundred and thirty-five axSpA patients participated in the survey. Eighty-four percent of the participants responded that there is a need to develop an axSpA-specific exercise app, and the same proportion want to use it. Patients under 60 years, patients under 60 years on biologics or Janus kinase inhibitor therapy, and patients with frequent back pain reported a greater need than their respective control subgroups (p < 0.001 in each case). CONCLUSION: The development of an exercise app for axSpA is considered necessary by a large proportion of the patients; younger and more intensively treated patients appear to have a greater need.
format Online
Article
Text
id pubmed-10076400
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-100764002023-04-07 Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis? Strunz, Patrick-Pascal Maire, Maxime Le Heusinger, Tobias Hammel, Ludwig Gernert, Michael Schwaneck, Eva C. Callhoff, Johanna Portegys, Jan Schmalzing, Marc Tony, Hans-Peter Froehlich, Matthias Z Rheumatol Originalien BACKGROUND: Digital health applications/apps (DiGA) are entering many medical disciplines and have the potential to revolutionize patient care. In rheumatology, the use for axial spondyloarthritis (axSpA) would be conceivable in the form of an exercise app. Therefore, a representative survey among axSpA patients was conducted to determine the need for an axSpA exercise app. MATERIALS AND METHODS: An anonymous online survey among axSpA patients of the German Bechterew’s Disease Association was conducted using a questionnaire; data were analysed using Excel, and GraphPad Prism. RESULTS: Four hundred and thirty-five axSpA patients participated in the survey. Eighty-four percent of the participants responded that there is a need to develop an axSpA-specific exercise app, and the same proportion want to use it. Patients under 60 years, patients under 60 years on biologics or Janus kinase inhibitor therapy, and patients with frequent back pain reported a greater need than their respective control subgroups (p < 0.001 in each case). CONCLUSION: The development of an exercise app for axSpA is considered necessary by a large proportion of the patients; younger and more intensively treated patients appear to have a greater need. Springer Medizin 2021-10-07 2023 /pmc/articles/PMC10076400/ /pubmed/34618212 http://dx.doi.org/10.1007/s00393-021-01104-1 Text en © The Author(s) 2021, korrigierte Publikation 2021 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Originalien
Strunz, Patrick-Pascal
Maire, Maxime Le
Heusinger, Tobias
Hammel, Ludwig
Gernert, Michael
Schwaneck, Eva C.
Callhoff, Johanna
Portegys, Jan
Schmalzing, Marc
Tony, Hans-Peter
Froehlich, Matthias
Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title_full Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title_fullStr Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title_full_unstemmed Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title_short Apps in der Rheumatologie: Bedarf es einer App in der Therapie der axialen Spondyloarthritis?
title_sort apps in der rheumatologie: bedarf es einer app in der therapie der axialen spondyloarthritis?
topic Originalien
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076400/
https://www.ncbi.nlm.nih.gov/pubmed/34618212
http://dx.doi.org/10.1007/s00393-021-01104-1
work_keys_str_mv AT strunzpatrickpascal appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT mairemaximele appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT heusingertobias appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT hammelludwig appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT gernertmichael appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT schwaneckevac appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT callhoffjohanna appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT portegysjan appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT schmalzingmarc appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT tonyhanspeter appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis
AT froehlichmatthias appsinderrheumatologiebedarfeseinerappindertherapiederaxialenspondyloarthritis